Quipt Home Medical (QIPT) Stock Price, News & Analysis

Company Overview

Quipt Home Medical (NASDAQ: QIPT) is a U.S.-based provider of home medical equipment and related services, specializing in respiratory care and sleep therapy. The company offers a comprehensive range of durable medical equipment (DME) designed to support patients with chronic respiratory conditions, sleep apnea and other pulmonary disorders in the comfort of their own homes.

Key product offerings include continuous positive airway pressure (CPAP) and bilevel devices, oxygen concentrators, noninvasive ventilators, masks, tubing and disposables. Beyond equipment sales and rentals, Quipt Home Medical delivers patient education, clinical support and remote monitoring services. Its network of respiratory therapists and trained staff works directly with physicians, sleep labs and durable medical equipment suppliers to ensure timely delivery, set-up and ongoing patient compliance.

Operating through a nationwide footprint, Quipt Home Medical serves patients across multiple states through a combination of corporate locations and strategic partnerships. The company’s infrastructure supports centralized billing and logistics, enabling efficient order processing and rapid dispatch of equipment. Quipt Home Medical adheres to industry standards and regulatory requirements, maintaining accreditation from key organizations in the DME sector. Through its focus on clinical excellence and customer service, the company aims to improve patient outcomes and quality of life for individuals requiring home respiratory care.

Key Stats

• Today's Range: $2.56 to $2.63
• 50-Day Range: $1.73 to $2.65
• 52-Week Range: $1.35 to $3.27
• Volume: 169,023 shs
• Average Volume: 828,129 shs
• Market Capitalization: $112.51 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: $3.15
• Consensus Rating: Moderate Buy

Quipt Home Medical Stock Analysis - MarketRank™

Quipt Home Medical scored higher than 52% of companies evaluated by MarketBeat, and ranked 562nd out of 928 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 3.2 / 5
• Analyst Rating: Moderate Buy

Consensus Rating

Quipt Home Medical has received a consensus rating of Moderate Buy. The company's average rating score is 2.50, and is based on 1 buy rating, 1 hold rating, and no sell ratings.

Upside Potential

Quipt Home Medical has a consensus price target of $3.15, representing about 21.6% upside from its current price of $2.59.

Amount of Analyst Coverage

Quipt Home Medical has only been the subject of 1 research reports in the past 90 days.

Earnings and Valuation

• Score: 0.0 / 5
• Proj. Earnings Growth: Decreasing

Earnings Growth

Earnings for Quipt Home Medical are expected to decrease in the coming year, from ($0.05) to ($0.13) per share.

Price to Earnings Ratio vs. the Market

The P/E ratio of Quipt Home Medical is -10.79, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Earnings Ratio vs. Sector

The P/E ratio of Quipt Home Medical is -10.79, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Book Value per Share Ratio

Quipt Home Medical has a P/B Ratio of 1.04. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

Short Interest

• Score: 5.0 / 5
• Short Interest Level: Healthy

Percentage of Shares Shorted

2.57% of the float of Quipt Home Medical has been sold short.

Short Interest Ratio / Days to Cover

Quipt Home Medical has a short interest ratio ("days to cover") of 1.6, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in Quipt Home Medical has recently decreased by 6.77%, indicating that investor sentiment is improving significantly.

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

Quipt Home Medical does not currently pay a dividend.

Dividend Growth

Quipt Home Medical does not have a long track record of dividend growth.

Sustainability and ESG

• Score: N/A
• Environmental Score: N/A

Percentage of Shares Shorted

2.57% of the float of Quipt Home Medical has been sold short.

Short Interest Ratio / Days to Cover

Quipt Home Medical has a short interest ratio ("days to cover") of 1.6, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in Quipt Home Medical has recently decreased by 6.77%, indicating that investor sentiment is improving significantly.

News and Social Media

• Score: 2.9 / 5
• News Sentiment: 1.19

News Sentiment

Quipt Home Medical has a news sentiment score of 1.19. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.72 average news sentiment score of Medical companies.

News Coverage This Week

MarketBeat has tracked 2 news articles for Quipt Home Medical this week, compared to 2 articles on an average week.

Search Interest

1 people have searched for QIPT on MarketBeat in the last 30 days.

Company Ownership

• Score: 1.7 / 5
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, Quipt Home Medical insiders have not sold or bought any company stock.

Percentage Held by Insiders

13.40% of the stock of Quipt Home Medical is held by insiders. A high percentage of insider ownership can be a sign of company health.

Percentage Held by Institutions

42.85% of the stock of Quipt Home Medical is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

QIPT Stock Analysis - Frequently Asked Questions

How have QIPT shares performed this year?

Quipt Home Medical's stock was trading at $3.05 at the beginning of 2025. Since then, QIPT stock has decreased by 15.1% and is now trading at $2.59.

How were Quipt Home Medical's earnings last quarter?

Quipt Home Medical Corp. (NASDAQ:QIPT) issued its earnings results on Monday, August, 11th. The company reported ($0.07) EPS for the quarter, missing the consensus estimate of $0.03 by $0.10. The company earned $58.30 million during the quarter, compared to analysts' expectations of $80.37 million. Quipt Home Medical had a negative net margin of 4.30% and a negative trailing twelve-month return on equity of 9.78%.
Read the conference call transcript.

Who are Quipt Home Medical's major shareholders?

Quipt Home Medical's top institutional investors include Claret Asset Management Corp (9.75%), Kanen Wealth Management LLC (4.44%), Franklin Resources Inc. (1.90%) and Arrowstreet Capital Limited Partnership (1.45%).
View institutional ownership trends.

How do I buy shares of Quipt Home Medical?

Shares of QIPT stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

What other stocks do shareholders of Quipt Home Medical own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Quipt Home Medical investors own include Invesco QQQ (QQQ), SPDR S&P 500 ETF Trust (SPY), SPDR Dow Jones Industrial Average ETF Trust (DIA), Meta Platforms (META), NVIDIA (NVDA), Advanced Micro Devices (AMD) and Tesla (TSLA).

Company Calendar

• Last Earnings: 8/11/2025
• Today: 9/07/2025
• Fiscal Year End: 9/30/2025

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Medical
• Industry: MED PRODUCTS
• Sub-Industry: Healthcare
• Current Symbol: NASDAQ:QIPT
• CIK: 1540013
• Web: www.protechhomemedical.com
• Phone: 859-878-2220
• Fax: N/A
• Employees: 1,200
• Year Founded: N/A

Price Target and Rating

• Average Price Target for Quipt Home Medical: $3.15
• High Price Target: $4.00
• Low Price Target: $2.30
• Potential Upside/Downside: +21.6%
• Consensus Rating: Moderate Buy
• Rating Score (0-4): 2.50
• Research Coverage: 2 Analysts

Profitability

• EPS (Trailing Twelve Months): ($0.24)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: -$6.76 million
• Net Margins: -4.30%
• Pretax Margin: -4.35%
• Return on Equity: -9.78%
• Return on Assets: -4.23%

Debt

• Debt-to-Equity Ratio: 0.71
• Current Ratio: 1.15
• Quick Ratio: 0.75

Sales & Book Value

• Annual Sales: $245.91 million
• Price / Sales: 0.46
• Cash Flow: $1.02 per share
• Price / Cash Flow: 2.55
• Book Value: $2.49 per share
• Price / Book: 1.04

Miscellaneous

• Outstanding Shares: 43,440,000
• Free Float: 37,623,000
• Market Cap: $112.51 million
• Optionable: Optionable
• Beta: 0.60